Search

Your search keyword '"Rogan, Jane"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Rogan, Jane" Remove constraint Author: "Rogan, Jane"
39 results on '"Rogan, Jane"'

Search Results

2. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

3. Data from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

4. Supplementary Figure S1 - S3 from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

5. Supplementary Table S1 from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

6. Supplementary Methods from Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

7. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

8. Nano-scavengers for blood biomarker discovery in ovarian carcinoma

9. The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA

11. Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome

12. Abstract B49: “Triple wild-type” co-mutational profile in early-stage KRAS-mutant lung cancer

14. Breast Cancer pN Staging with Deep Learning

15. Fc effector function contributes to the activity of human anti-CTLA-4 antibodies

16. Abstract 1763: Tumor mutational burden, mutational signatures and copy number variation in lung cancer driven by the Ras-Raf-MEK-ERK pathway

17. Human In Vivo Corona: The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study (Adv. Mater. 4/2019)

18. Fc-Optimized Anti-CD25 depletes tumor-infiltrating regulatory T Cells and synergizes with PD-1 Blockade to eradicate established tumors

19. Blood-based mutation testing: concordance with tissue-based testing and mutational changes on progression.

21. The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers

22. PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours

23. Increased peri-ductal collagen micro-organization may contribute to raised mammographic density

24. Additional file 3: Table S2. of Increased peri-ductal collagen micro-organization may contribute to raised mammographic density

25. Additional file 2: Table S1. of Increased peri-ductal collagen micro-organization may contribute to raised mammographic density

26. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

27. Abstract 470: Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma

28. Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

29. Increased peri-ductal collagen micro-organization may contribute to raised mammographic density

30. Abstract 2432: A technology platform for personalized medicine in melanoma

31. Optimizing sharing of hospital biobank samples

32. A national platform for molecular diagnostics: Results of the Cancer Research U.K. Stratified Medicine Programme.

33. Emerging findings in the Cancer Research UK stratified medicine program.

34. Never too late for a kind word

39. Reinventing YIG Technology for Microwave Filter Applications.

Catalog

Books, media, physical & digital resources